Trigyn Technologies Intrinsic Value
Trigyn Technologies intrinsic value. Trigyn Technologies (TRIGYN) median intrinsic value is ₹68.03 from 8 valuation models (range ₹16–₹129), vs current price ₹51.70 — +31.6% upside (Trading Below Calculated Value), margin of safety 24.0%. For current market price and key ratios, visit Trigyn Technologies stock price NSE.
TRIGYN Valuation Methods Summary — DCF, Graham Number & P/E
Trigyn Technologies intrinsic value across 8 models vs current price ₹51.70 — upside/downside and value range per method. Compare with TRIGYN fair value to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹15.51 | ₹12.41 - ₹18.61 | -70.0% | EPS: ₹0.80, Sector P/E: 12x |
| Book Value Method | asset | ₹129.25 | ₹116.33 - ₹142.18 | +150.0% | Book Value/Share: ₹257.10, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹103.40 | ₹93.06 - ₹113.74 | +100.0% | Revenue/Share: ₹330.32, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹61.94 | ₹55.75 - ₹68.13 | +19.8% | EBITDA: ₹32.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹129.25 | ₹103.40 - ₹155.10 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹15.51 | ₹13.96 - ₹17.06 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹15.51 | ₹13.96 - ₹17.06 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹68.03 | ₹61.23 - ₹74.83 | +31.6% | EPS: ₹0.80, BVPS: ₹257.10 |
TRIGYN Intrinsic Value vs Market Price — All Valuation Models
Trigyn Technologies fair value range ₹16–₹129 vs current market price ₹51.70 across 8 valuation models. Read TRIGYN dividend history for the complete payout history and dividend yield track record.
TRIGYN Intrinsic Value Analysis — Undervalued or Overvalued?
Trigyn Technologies median intrinsic value ₹68.03, current price ₹51.70 — Trading Below Calculated Value by 31.6%, margin of safety 24.0%.
What is the intrinsic value of TRIGYN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Trigyn Technologies (TRIGYN) is ₹68.03 (median value). With the current market price of ₹51.70, this represents a +31.6% variance from our estimated fair value.
The valuation range spans from ₹15.51 to ₹129.25, indicating ₹15.51 - ₹129.25.
Is TRIGYN undervalued or overvalued?
Based on our multi-method analysis, Trigyn Technologies (TRIGYN) appears to be trading below calculated value by approximately 31.6%.
TRIGYN Financial Health — Key Ratios vs Industry Benchmarks
Trigyn Technologies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 49.38 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 0.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.04x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
TRIGYN Cash Flow Quality — Operating & Free Cash Flow
Trigyn Technologies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹52 Cr | ₹52 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹126 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-52 Cr | ₹-63 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹45 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹80 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |